# Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD)

> **NCT00396604** · PHASE2,PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 51 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive
- COPD
- Lung Diseases, Obstructive

## Interventions

- **DRUG:** indacaterol maleate

## Key facts

- **NCT ID:** NCT00396604
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2011-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00396604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00396604, "Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00396604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*